InMed Pharmaceuticals
(NASDAQ) INM
InMed Pharmaceuticals Financials at a Glance
Market Cap
$2.39M
Revenue (TTM)
$5.28M
Net Income (TTM)
$9.07M
EPS (TTM)
$-3.78
P/E Ratio
-0.22
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$0.85
Volume
100
Open
$0.85
Price
$0.85
Volume
100
Open
$0.85
Previous Close
$0.85
Daily Range
$0.85 - $0.85
52-Week Range
$0.73 - $7.98
Dividend
$0.00
Beta (Volatility)
1.33 (Average)
Price
$0.85
Volume
100
Open
$0.85
Previous Close
$0.85
Daily Range
$0.85 - $0.85
52-Week Range
$0.73 - $7.98
INM News
INM: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout InMed Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
13
CEO
Eric A. Adams
Website
www.inmedpharma.comHeadquarters
Vancouver, BC V6C 1B4, CA
INM Financials
Key Financial Metrics (TTM)
Gross Margin
26%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
-97%
Return on Capital
-69%
Return on Assets
-59%
Earnings Yield
-4.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.39M
Shares Outstanding
2.92M
Volume
100
Short Interest
0.00%
Avg. Volume
86.26K
Financials (TTM)
Gross Profit
$1.71M
Operating Income
$7.92M
EBITDA
$7.26M
Operating Cash Flow
$7.77M
Capital Expenditure
$0.00
Free Cash Flow
$7.77M
Cash & ST Invst.
$15.09M
Total Debt
$1.01M
InMed Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.13M
+1.2%
Gross Profit
$35.91K
-92.2%
Gross Margin
3.19%
N/A
Market Cap
$2.39M
N/A
Market Cap/Employee
$184.13K
N/A
Employees
13
N/A
Net Income
$2.78M
-8.1%
EBITDA
$2.69M
-28.6%
Quarterly Fundamentals
Net Cash
$8.87M
+149.8%
Accounts Receivable
$251.05K
-33.5%
Inventory
$947.90M
+59639.3%
Long Term Debt
$169.91K
-77.7%
Short Term Debt
$560.18K
-7.2%
Return on Assets
-59.02%
N/A
Return on Invested Capital
-69.22%
N/A
Free Cash Flow
$3.23M
-29.0%
Operating Cash Flow
$3.23M
-29.0%